A team of Pillsbury lawyers represented JSR Corporation, a multinational  company headquartered in Tokyo focused on digital solutions business, life science business and more, in its agreement to acquire Inpria Corporation, the world’s leading innovator of metal oxide photoresist design, development and manufacturing for extreme ultraviolet (EUV) lithography, for $514 million (as the entire enterprise value including the value of shares already owned by JSR).

In 2017 and 2020, JSR participated in Inpria’s funding rounds which resulted in JSR owning 21 percent of the company’s outstanding shares. Through this deal, JSR will acquire the remaining shares and Inpria will become a wholly owned subsidiary of JSR Corporation.

JSR recently pivoted to focus its business and future expansion on its digital solutions, which includes semiconductor materials, and life sciences businesses, both of which are targeted to drive growth and leverage the company’s strengths in technological innovation. Headquartered in Tokyo with offices throughout Asia, Europe and the U.S., JSR plans to leverage decades of experience in high volume manufacturing, quality control, supplier management and customer engagement to further strengthen its ability to support and enable the IC industry. This acquisition will bring a key enhancement to JSR’s already robust product portfolio of leading-edge material solutions. 

Read more on the transaction here.

The Pillsbury team is led by Corporate partners Christopher Patay and Tai Kimoto and includes Corporate associates Jeong Choi and Hana Cho.